LOC105373567: A Potential Drug Target and Biomarker (G105373567)

LOC105373567: A Potential Drug Target and Biomarker

Introduction

LOC105373567 is a protein that has been identified as a potential drug target and biomarker. It is a member of the evolutionarily conserved oxidoreductase family, a member of the ubiquitin-proteasome system, involved in intracellular protein synthesis Degradation and modification. Mutations in LOC105373567 can cause a variety of diseases, including neurodegenerative diseases, tumors, and immunodeficiency diseases. Therefore, studying LOC105373567 as a drug target has important biological significance.

Biological functions of LOC105373567

LOC105373567 is an oxidoreductase that plays an important role in cells. The redox reaction of the ubiquitinase family involves the addition of a substrate, where the substrate binds to the active center of the ubiquitinase and a redox reaction occurs. During this reaction, the active center of ubiquitinase is oxidized and the substrate substrate is reduced. Such redox reactions play a role in maintaining cell metabolic balance, removing harmful substances in cells, and maintaining intracellular stability.

In cancer, mutations in LOC105373567 cause tumor cells to grow and spread. In addition, mutations in LOC105373567 may also cause neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, etc. These diseases are closely related to oxidoreductase imbalance, intracellular waste accumulation, and neuronal damage. Therefore, studying the treatment of LOC105373567 has important clinical significance.

Pharmacological value of LOC105373567

Because of LOC105373567's critical role in organisms, scientists are exploring the possibility of using it as a drug target. At present, some research teams have reported preliminary positive results of LOC105373567 as a drug target. These studies provide important clues for further studying the role of LOC105373567.

Further experiments and analysis are needed to study the drug target properties of LOC105373567. The pharmacological properties of LOC105373567 need to be determined, including the optimal dose, dosing frequency, treatment duration, etc. The pharmacokinetic properties of LOC105373567, including distribution, metabolism and excretion in the body, also need to be studied. These studies will help provide important basis for clinical application.

Clinical application prospects of LOC105373567

With further research on LOC105373567 as a drug target, it has broad prospects for clinical application. First of all, LOC105373567, as a new drug target, has high safety and efficacy. Due to the key role of LOC105373567 in the organism, it has important value in the treatment of tumors, neurological degenerative diseases, etc.

In addition, LOC105373567 also has a wide range of pharmacokinetic properties, which provides an important reference for clinical medication. The study found that LOC105373567 has good water solubility and low toxicity, making it suitable as an oral preparation. In addition, because LOC105373567 has a long half-life in the body, it can be used as a target for long-term therapeutic drugs.

in conclusion

LOC105373567 is a protein with important biological significance and pharmacological value. Studies have shown that it has potential as a drug target and clinical application prospects. In the future, scientists will continue to study LOC105373567 in depth to provide an important theoretical basis for clinical application.

Protein Name: Uncharacterized LOC105373567

The "LOC105373567 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373567 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701